Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation. [electronic resource]
Producer: 20191223Description: 94-99 p. digitalISSN:- 1523-6536
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- Chronic Disease
- Disease-Free Survival
- Female
- Graft vs Host Disease -- mortality
- Hematologic Neoplasms -- mortality
- Hematopoietic Stem Cell Transplantation
- Humans
- Male
- Risk Factors
- Survival Rate
- Transplantation, Homologous
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
There are no comments on this title.
Log in to your account to post a comment.